Aurobindo Pharma has entered into binding agreements to invest Rs 5.38 crore each in NVNR (Ramannapet I) Power Plant and NVNR (Ramannapet II) Power Plant, aggregating to Rs 10.76 crore. The company has invested in the two firms to avail the benefit of captive consumption of solar power. After making the said investments, the company will be holding 26 percent of the share capital in each of the aforesaid solar power generating companies.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
